「A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor」の関連論文
-
Anti-nucleolin aptamer, iSN04, inhibits the inflammatory responses in C2C12 myoblasts by modulating the β-catenin/NF-κB signaling pathway
-
Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis
-
Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection
-
A study on the immunostimulatory effects of alarmin HMGN1 in cancer immunity
-
Mechanisms by which Bacterial and Viral Pathogens cause Ovarian dysfunction
-
Antitumor effect of regorafenib on microRNA expression in hepatocellular carcinoma cell lines
-
CDK8/19 inhibition plays an important role in pancreatic β-cell induction from human iPSCs
-
The identification of novel small extracellular vesicle (sEV) production modulators using luciferase‐based sEV quantification method
-
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells
-
Growth and Migration Blocking Effect of Nanaomycin K, a Compound Produced by Streptomyces sp., on Prostate Cancer Cell Lines In Vitro and In Vivo
-
MECHANISTIC ANALYSIS OF THE INITIATION OF RETROVIRAL GENE SILENCING BY REPROGRAMMING FACTORS
-
Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes
-
Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon
-
PML-RARαはMED1との結合を介して全トランス型レチノイン酸依存性の転写活性化を誘導する
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
iPSC screening for drug repurposing identifies anti‐RNA virus agents modulating host cell susceptibility
-
Study on the biological significance of YAP gene alternative splicing
-
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
-
Luteolin suppress bladder cancer growth via regulation of mechanistic target of rapamycin (mTOR) pathway
-
AITC inhibits fibroblast-myofibroblast transition via TRPA1-independent MAPK and NRF2/HO-1 pathways and reverses corticosteroids insensitivity in human lung fibroblasts
-
The PDGF receptor alpha signal regulates the senescence of neural stem cells and their niche via the close functional correlation with NAD
-
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells
-
CD44v9 Induces Stem Cell-Like Phenotypes in Human Cholangiocarcinoma
-
The ATR inhibitor AZD6738 increases the sensitivity of 5-fluorouracil in colorectal cancer cells by abrogating repair of DNA damage
-
Identification of PTPRσ-interacting proteins by proximity-labelling assay
-
S-1-Propenylcysteine promotes IL-10-induced M2c macrophage polarization through prolonged activation of IL-10R/STAT3 signaling
-
S-1-Propenylcysteine promotes IL-10-induced M2c macrophage polarization through prolonged activation of IL-10R/STAT3 signaling
-
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
-
Setd1a plays pivotal roles for the survival and proliferation of retinal progenitors via histone modifications of Uhrf1
-
Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice
-
Design of Novel Targeted Co-delivery System for Combined Chemotherapy and Gene Therapy of Hepatocellular Carcinoma [an abstract of entire text]
-
Generation of molecular-targeting peptides for selective inhibition of the interaction between CTLA-4 and B7 in the dog: a new immune checkpoint inhibitor for cancer therapy
-
Cathepsin K Activity Controls Cachexia-induced Muscle Atrophy via the Modulation of IRS1 Ubiquitination
-
PCBP2 knockdown promotes ferroptosis in malignant mesothelioma
-
Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1
-
Studies on development of novel therapeutic agent against RNA virus infection
-
Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells
-
Tumor elimination by clustered microRNAs miR-306 and miR-79 via noncanonical activation of JNK signaling
-
Research for elucidation of immune evasion mechanisms and development of a novel immunotherapy for cancer in dogs [an abstract of entire text]
-
Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
-
Cutaneous Liver X Receptor Activation Prevents the Formation of Imiquimod-Induced Psoriatic Dermatitis
-
SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization
-
Regulation Mechanisms of Transcription Factor BACH1 by TANK Binding Kinase 1
-
BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance
-
Efficacy of the Novel Tubulin Polymerization Inhibitor PTC-028 for Myelodysplastic Syndrome
-
Myogenetic Oligodeoxynucleotides as Anti-Nucleolin Aptamers Inhibit the Growth of Embryonal Rhabdomyosarcoma Cells
-
Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest
-
Functional and genomic characterization of patient-derived xenograft model to study adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma
-
Secretory expression of mammalian NOTCH tandem epidermal growth factor-like repeats based on increased O-glycosylation
-
The effects of CREBH on ChREBP-mediated hepatic fructose metabolism